Hasty Briefsbeta

Bilingual

Multiple Myeloma: Diagnosis and Treatment - PubMed

5 hours ago
  • #cancer diagnosis
  • #multiple myeloma
  • #hematologic malignancy
  • Multiple myeloma is a hematologic malignancy of plasma cells, causing excessive monoclonal protein production.
  • It accounts for 36,000 new cancer diagnoses annually in the U.S., with a median diagnosis age of 69.
  • Symptoms include bone pain, fatigue, anemia, weight loss, kidney failure, and hypercalcemia; some patients are asymptomatic.
  • Initial evaluation involves blood tests, metabolic panels, serum calcium, urinalysis, protein electrophoresis, and imaging.
  • Diagnosis requires urine/serum protein electrophoresis, immunofixation, free light chain assay, imaging, and bone marrow analysis.
  • Oncology referral is recommended if initial tests suggest multiple myeloma.
  • Treatment involves a 3-4 drug regimen, autologous stem cell transplantation if eligible, and maintenance therapy.
  • Adjunctive care includes bisphosphonates/denosumab and venous thromboembolism prophylaxis.
  • Family physicians are key in addressing psychosocial needs, identifying relapse, and managing comorbidities.